Fatty Liver Disease (FLD) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease （OCEAN PROJECT）
Conditions: Nonalcoholic Fatty Liver Disease; Chronic Hepatitis b Interventions: Drug: Peg-Interferon α Sponsors: First Affiliated Hospital of Wenzhou Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials

Implementation of the Fatty Liver Index in Primary Care
Conditions: Hepatic Steatosis; Overweight and Obesity Interventions: Other: FLI Sponsors: Consorci Sanitari de l ' Alt Pened ès i Garraf Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials

The Study of Lithogenesis Processes in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
Conditions: NAFLD; Urinary Lithiasis Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Drug: Empagliflozin 10 MG; Drug: Placebo Oral Tablet Sponsors: Ann& Robert H Lurie Children ' s Hospital of Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials

Human Models of Selective Insulin Resistance: Alpelisib, Part I
Conditions: Insulin Resistance; Prediabetic State; Overweight and Obesity; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Alpelisib 300 mg; Drug: Placebo; Drug: [1-13C] sodium acetate; Drug: [6,6-2H2] D-glucose; Dietary Supplement: Nestl é BOOST Plus Sponsors: Columbia University; University of California, Berkeley Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials

Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Behavioral: Motivational Interview; Behavioral: Placebo Sponsors: Madunil Anuk Niriella Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials

Manual Therapy in Metabolic Liver Disease
Conditions: NAFLD, Non-alcoholic Fatty Liver Disease Interventions: Procedure: liver treatment protocol Sponsors: University of Seville Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials

The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic Fatty Liver Disease
Conditions: Non-alcoholic Fatty Liver Disease NAFLD Interventions: Behavioral: Aerobic training (AT); Behavioral: Resistance training (RT); Behavioral: Combined aerobic and resistance training (AT + RT) Sponsors: Xuzhou Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
Conditions: Obesity; Nonalcoholic Fatty Liver; Diabetes Type 2; Healthy Interventions: Other: Dietary consultation weight loss intervention Sponsors: Bettina Mittendorfer; National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials

A Multicenter, Retrospective Clinical Study on the Clinical Characteristics of Metabolic Associated Fatty Liver Disease
Conditions: Metabolic Associated Fatty Liver Disease; Clinical Features Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials

Clinical Characteristics of Metabolic Associated Fatty Liver Disease
Conditions: Metabolic Associated Fatty Liver Disease; Clinical Features Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials

Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLD
Conditions: Fatty Liver, Nonalcoholic Sponsors: Singapore Institute of Technology; Singapore Health Services Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Lifestyle intervention in children with obesity and nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled trial in Ningbo city (the SCIENT study)
This study aimed to develop an m-Health-assisted lifestyle intervention program targeting overweight/obese children and assess its effectiveness on indicators of adiposity and NAFLD.MethodsThis is a cluster-randomized controlled trial that conducted in children with overweight/obesity in Ningbo city, Zhejiang Province, China. Students in Grade 3 (8 –10 years old) were recruited from six primary schools, with three be randomized to intervention group and three to usual practice group. The intervention program will last for one academic year and consists of health education, dietary guidance, and physical activity reinfor...
Source: Trials - March 20, 2024 Category: Research Source Type: clinical trials

Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis
Conditions: Fatty Liver Disease; Steatohepatitis, Nonalcoholic Interventions: Drug: Esomeprazole; Drug: Placebo Sponsors: Sadat City University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes
Conditions: Type2diabetes Sponsors: Medanta, The Medicity, India Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials